Dystroglycan: An extracellular matrix receptor linked to the cytoskeleton

Current Opinion in Cell Biology

Volumn 8, Issue 5, 1996, Pages 625-631

  Henry, Michael D ^a   Campbell, Kevin P ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROGLYCAN; GLYCOPROTEIN; MUSCLE PROTEIN; RECEPTOR; SCLEROPROTEIN;

AMINO ACID SEQUENCE; BASEMENT MEMBRANE; CYTOSKELETON; EXTRACELLULAR MATRIX; MUSCULAR DYSTROPHY; NEUROMUSCULAR SYNAPSE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; SARCOLEMMA; SKELETAL MUSCLE; STRUCTURE ACTIVITY RELATION;

EID: 0030272647     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(96)80103-7     Document Type: Article

References (69)

1. Campbell KP, Kahl SD: Association of dystrophin and an integral membrane glycoprotein. Nature 19B9, 338:259-262.
2. Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP: Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 1990, 345:315-319.
3. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP: Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 1992, 355:696-702.
4. Suzuki A, Yoshida M, Hayashi K, Mizuno Y, Hagiwara Y, Ozawa E: Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy terminal portion of dystrophin. Eur J Biochem 1994, 220:283-292.
5. Jung D, Yang B, Meyer J, Chamberlain JS, Campbell KP: Identification and characterization of the dystrophin anchoring site on β-dystroglycan. J Biol Chem 1995, 270:27305-27310. Using solution binding assays, the authors conducted detailed analyses of both the dystroglycan-binding site on dystrophin and vice versa. The data agree with those in [4] and show that the carboxy-terminal 15 amino acids of β-dystroglycan are sufficient for binding to dystrophin.
6. Campbell KP: Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 1995, 80:675-679.
7. Bowe MA, Deyst KA, Leszyk JD, Fallen JF: Identification and purification of an agrin receptor from Torpedo postsynaptic membranes: a heteromeric complex related to the dystroglycans. Neuron 1994, 12:1173-1180.
8. Campanelli JT, Roberds SL, Campbell KP, Scheller RH: A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AChR clustering. Cell 1994, 77:663-674.
9. Gee SH, Montanaro F, Lindenbaum MH, Carbonetto S: Dystroglycan-α, a dystrophin-associated glycoprotein is a functional agrin receptor. Cell 1994, 77:675-686.
10. Sugiyama J, Bowen DC, Hall ZW: Dystroglycan binds nerve and muscle agrin. Neuron 1994, 13:103-115.
11. Ibraghimov-Beskrovnaya O, Milatovich A, Ozcelik T, Yang B, Koepnick K, Francke U, Campbell KP: Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum Mol Genet 1993, 2:1651-1657.
12. Yoshida M, Suzuki A, Yammamoto H, Noguchi S, Mizuno Y, Ozawa E: Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl β-D-glucoside. Eur J Biochem 1994, 222:1055-1061.
13. Gorecki DC, Derry JMJ, Barnard EA: Dystroglycan: brain localisation and chromosome mapping in the mouse. Hum Mol Genet 1994, 3:1589-1597.
14. Smalheiser NR, Kim E: Purification of cranin, a laminin binding membrane protein. J Biol Chem 1995, 270:15425-15433. The authors identified cranin as brain-derived dystroglycan. They proposed a mucin-like carbohydrate structure for dystroglycan on the basis of several lines of evidence. They also mapped the position of the amino terminus of β-dystroglycan.
15. Deyst KA, Bowe MA, Leszyk JD, Fallon JR: The α-dystroglycan-β-dystroglycan complex membrane organization and relationship to an agrin receptor. J Biol Chem 1995, 270:25956-25959.
16. Ervasti JM, Campbell KP: Membrane organization of the dystrophin-glycoprotein complex. Cell 1991, 66:1121-1131.
17. Ervasti JM, Campbell KP: A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993, 122:809-823.
18. Yamada H, Chiba A, Endo T, Kobata A, Anderson LVB, Hori H, Fukuta-Ohi H, Kanazawa I, Campbell KP, Shimizu T, Matsumura K: Characterization of dystroglycan-laminin interaction in peripheral nerve. J Neurochem 1996, 66:1518-1524.
19. Brancaccio A, Schulthess T, Gesemann M, Engel J: Electron microscopic evidence for a mucin-like region in chick muscle α-dystroglycan. FEBS Lett 1995, 368:139-142. An intriguing 'dumbbell-shaped' structure is seen for α-dystroglycan by electron microscopy.
20. Cullen MJ, Walsh J, Roberds SL, Campbell KP: Ultrastructural localization of adhalin, α-dystroglycan and merosin in normal and dystrophic muscle. Neuropathol Appl Neurobiol 1996, 22:30-37. Describes the electron microscopic study of the DGC in situ, α-dystroglycan appears to reach out a considerable distance from the plasma membrane to touch laminin-2; this result argues in favor of an extended structure for α-dystroglycan.
21. Yamada H, Shimizu T, Tanaka T, Campbell KP, Matsumura K: Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett 1994, 352:49-53.
22. Yamada H, Denzer AJ, Hori H, Tanaka T, Anderson LVB, Fujita S, Fukata-Ohi H, Shimizu T, Ruegg MA, Matsumura K: Dystroglycan is a dual receptor for agrin and laminin-2 in schwann cell membrane. J Biol Chem 1996, in press. Among other findings, the authors show that endogenous agrin and laminin-2 compete for binding to peripheral nerve dystroglycan.
23. Pall EA, Bolton KM, Ervasti JM: Differential heparin inhibition of skeletal muscle α-dystroglycan binding to laminins. J Biol Chem 1996, 271:3817-3821. These results, together with those of [25*], have implications for understanding the regulation of dystroglycan-ligand interactions. Furthermore, they indicate that laminin-1 and laminin-2 are not functionally redundant [23*].
24. Gesemann M, Cavalli V, Denzer AJ, Brancaccio A, Schumacher B, Ruegg MA: Alternative splicing of agrin alters its binding to heparin, dystroglycan, and the putative agrin receptor. Neuron 1996, 16:755-767. A careful study which, among other things, measured the binding of agrin fragments to the surface of cultured myotubes. Taken together, the data argue for the existence of an agrin receptor other than α-dystroglycan that is responsible for mediating AChR clustering.
25. OToole JJ, Deyst KA, Bowe MA, Nastuk MA, McKechnie BA, Fallon JR: Alternative splicing of agrin regulates its binding to heparin, α-dystroglycan, and the cell surface. Proc Natl Acad Sci USA 1996, in press. These authors show that the alternatively spliced heparin-binding site on agrin is necessary for heparin inhibition of agrin binding to dystroglycan.
26. Jung D, Leturcq F, Sunada Y, Duclos F, Tome FMS, Moomaw C, Merlini L, Azibi K, Chaouch M, Slaughter C et al.: Absence of γ-sarcoglycan (35 DAG) in autosomal recessive muscular dystrophy linked to chromosome 13q12. FEBS Lett 1996, 381:15-20.
27. Roberds SL, Leturcq F, Allamand V, Piccolo F, Jeanpierre M, Anderson RD, Lim LE, Lee JC, Tome FMS, Romero NB et al.: Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell 1994, 78:625-633.
28. Lim LE, Duclos F, Broux O, Bourg N, Sunada Y, Allamand V, Meyer J, Richard I, Moomaw C, Slaughter C et al.: β-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet 1995, 11:257-265.
29. Bonnemann CG, Modi R, Noguchi S, Mizuno Y, Yoshida M, Gussoni M, McNally EM, Duggan DJ, Angelini C, Huffman EP et al.: β-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet 1995, 11:266-272.
30. Noguchi S, McNally EM, Othmane KB, Hagiwara Y, Mizuno Y, Yoshida M, Yamamoto H, Bonnemann CG, Gussoni E, Denton PH et al.: Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy. Science 1995, 270:819-822.
31. Roberds SL, Ervasti JM, Anderson RD, Ohlendieck K, Kahl SD, Zoloto D, Campbell KP: Disruption of the dystrophin glycoprotein complex in the cardiomyopathic hamster. J Biol Chem 1993, 268:11496-11499.
32. Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, Meng G, Muller CR, Lindlof M, Kaariainen H et al.: The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 1989, 45:498-506.
33. Rafael JA, Cox GA, Jung D, Campbell KP, Chamberlain JS: Forced expression of dystrophin deletion constructs reveals structure function correlations. J Cell Biol 1996, 134:93-102. In this study, the authors generated transgenic mdx (dystrophin-deficient) mouse strains expressing a series of deletion constructs covering the carboxy-terminal domain of dystrophin. The results provide a critical in vivo test of the predictions made in [4,5**].
34. Bork P, Sudol M: The WW domain: a signalling site in dystrophin? Trends Biochem Sci 1994, 19:531-533.
35. Chan DC, Bedford MT, Leder P: Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains. EMBO J 1996, 15:1045-1054.
36. Yang B, Jung D, Motto D, Meyer J, Koretzky G, Campbell KP: SH3 domain-mediated interaction of dystroglycan and Grb2. J Biol Chem 1995, 270:11711-11714. Opens up the interesting possibility that dystroglycan is a signal transducing molecule.
37. Ohlendeick K, Campbell KP: Dystrophin-associated proteins are greatly reduced in the skeletal muscle from dystrophic mice. J Cell Biol 1992, 115:1685-1694.
38. Ohlendeick K, Matsumura K, lonasescu W, Towbin JA, Bosch EP, Weinstein SL, Sernett SW, Campbell KP: Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology 1993, 43:795-800.
39. Jimi T, Wakayama Y, Takeda A, Kobayashi T, Kumagai T, Suzuki Y, Hasegawa O, Yamashita S, Shibuya S, Kuroiwa Y, Misugi N: Altered distribution of β-dystroglycan in sarcolemma of human dystrophic muscles: an immunohistochemical study. Muscle Nerve 1995, 18:910-913.
40. Vater R, Harris JB, Anderson LVB, Roberds SL, Campbell KP, Cullen MJ: The expression of dystrophin-associated glycoproteins during skeletal muscle degeneration and regeneration. An immunofluorescence study. J Neuropathol Exp Neurol 1995, 54:557-569.
41. Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenbach J, Tome FM, Schwartz K, Fardeau M, Trygvasson K et al.: Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 1995, 11:216-218.
42. Xu H, Christmas P, Wu XR, Wewer DM, Engvall E: Murine muscular dustrophy caused by a mutation in the laminin α2 (Lama2) gene. Nat Genet 1994, 8:297-302.
43. 21 mice. Hum Mol Genet 1995, 4:1055-1061.
44. Cox GA, Sunada Y, Campbell KP, Chamberlain JS: Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nat Genet 1994, 8:333-339.
45. Greenberg DS, Sunada Y, Campbell KP, Yaffe D, Nudel U: Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice. Nat Genet 1994, 8:340-344.
46. Boudreau N, Sympson CJ, Weit Z, Bisseil MJ: Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995, 267:891-893.
47. Sealock R, Froehner SC: Dystrophin-associated proteins and synapse formation: is α-dystroglycan the agrin receptor? Cell 1994, 77:617-619.
48. Fallon JR, Hall ZW: Building synapses: agrin and dystroglycan stick together. Trends Neurosci 1994, 17:469-473.
49. Bowen DC, Sugiyama J, Ferns M, Hall ZW: Neural agrin activates a high-affinity receptor in C2 muscle cells that is unresponsive to muscle agrin. J Neurosci 1996, 16:3791-3797. A follow up to [10]. Soluble muscle agrin does not competitively inhibit neural agrin induced AChR clustering or phosphorylation, but does compete with neural agrin for binding to α-dystroglycan in blot overlay assays.
50. Hopf C, Hoch W: Agrin binding to α-dystroglycan: domains of agrin necessary to induce acetylcholine receptor clustering are overlapping but not identical to the α-dystroglycan binding region. J Biol Chem 1996, 271:5231-5236. First published work showing that the dystroglycan-binding and AChR-clustering domains of agrin are separable.
51. Valenzuela DM, Stitt TN, DiStefano PS, Rjoas E, Mattson K, Compton DL, Nunez L, Park JS, Stark JL, Gies DR et al.: Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury. Neuron 1995, 15:573-584.
52. DeChiara TM, Bowen DC, Valenzuela DM, Simmons MV, Poueymirou WT, Thomas S, Kinetz E, Compton DL, Rojas E, Park JS et al.: The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 1996, 85:501-512.
53. Glass DJ, Bowen DC, Stitt TN, Radziejewski C, Bruno J, Ryan TE, Gies DR, Shah S, Mattsson K, Burden SJ et al.: Agrin acts via a MuSK receptor complex. Cell 1996, 85:513-523. Implicates an agrin-binding accessory component (MASC) in MuSK-mediated signaling. Presents arguments against dystroglycan being MASC.
54. Kostrominova TY, Tanzer ML: Temporal and spatial appearance of α-dystroglycan in differentiated mouse myoblasts in culture. J Cell Biochem 1995, 58:527-534.
55. Apel ED, Roberds SL, Campbell KP, Merlie JP: Rapsyn may function as a link between the acetylcholine receptor and the agrin-binding dystrophin-associated glycoprotein complex. Neuron 1995, 15:115-126. This work in nonmuscle cells suggests that rapsyn has the capacity to recruit dystroglycan into AChR clusters.
56. Gautam M, Noakes PG, Mudd J, Nichol M, Chu GC, Sanes JR, Merlie JP: Failure of postsynaptic specialization to develop at the neuromuscular junctions of rapsyn-deficient mice. Nature 1995,377:232-236. The phenotype of a rapsyn knockout mouse shows that rapsyn is necessary for the construction of the postsynaptic AChR-cytoskeleton complex.
57. Cohen MW, Jacobson C, Godfrey EW, Campbell KP, Carbonetto S: Distribution of α-dystroglycan during embryonic nerve-muscle synaptogenesis. J Cell Biol 1995, 129:1093-1101. Focuses on AChR clustering induced by agrin in muscle-nerve cocultures. Shows that agrin deposits, AChR and α-dystroglycan clusters are in close temporal and spatial register.
58. Phillips WD, Noakes PG, Roberds SL, Campbell KP, Merlie JP: Clustering and immobilization of acetylcholine receptors by the 43-kD protein: a possible role for dystrophin-related protein. J Cell Biol 1993, 123:729-740.
59. Cartaud A, Ludosky MA, Haasemann M, Jung D, Campbell KP, Cartaud J: Non-neural agrin codistributes with acetylcholine receptors during early differentiation of Torpedo electrocytes. J Cell Sci 1996, in press.
60. Gee SH, Blacher RW, Douville PJ, Provost PR, Yurchenco PD, Carbonetto S: Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. J Biol Chem 1993, 268:14972-14980.
61. Matsumura K, Ervasti JM, Ohlendieck K, Kahl SD, Campbell KP: Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 1992, 360:588-591.
62. James M, Man NT, Wise CJ, Jones GE, Morris GE: Utrophin-dystroglycan complex in membranes of adherent cultured cells. Cell Motil Cytoskeleton 1996, 33:163-174.
63. Ohlendieck K, Ervasti JM, Matsumura K, Kahl SD, Leveille CJ, Campbell KP: Dystrophin-related protein is localized to the neuromuscular junctions of adult skeletal muscle. Neuron 1991, 7:499-508.
64. Bewick GS, Nicholson LVB, Young C, O'Donnel E, Slater CR: Different distributions of dystrophin and related proteins at nerve-muscle junctions. Neuroreport 1992, 3:857-860.
65. Durbeej M, Larsson E, Ibraghimov-Beskrovnaya O, Roberds SL, Campbell KP, Ekblom P: Non-muscle α-dystroglycan is involved in epithelial development J Cell Biol 1995, 130:79-91. Interesting demonstration of dystroglycan function outside of muscle tissue. Suggests that dystroglycan plays an important role in branching epithelial morphogenesis.
66. Montanaro F, Carbonetto S, Campbell KP, Lindanbaum M: Dystroglycan expression in the wild type and mdx mouse neural retina: synaptic colocalization with dystrophin, dystrophin related protein but not laminin. J Neurosci Res 1995,42:528-538.
67. Matsumura K, Yamada H, Shimizu T, Campbell KP: Differential expression of dystrophin, utrophin, and dystrophin-associated proteins in peripheral nerve. FEBS Lett 1993, 334:281-285.
68. Madrid RE, Jaros E, Cullen MJ, Bradley WG: Genetically determined defect of Schwann cell basement membrane in dystrophic mouse. Nature 1975, 257:319-321.
69. Schofield JN, Gorecki DC, Blake DJ, Davies K, Edwards YH: Dystroglycan mRNA expression during normal and mdx mouse embryogenesis: a comparison with utrophin and apodystrophins. Dev Dyn 1995, 204:178-185.